Hemoperfusion for organophosphate poisoning in critically ill patients- A randomized trial.
Not Applicable
Recruiting
- Conditions
- Injury, Occupational Diseases, Poisoning
- Registration Number
- PACTR202009754904918
- Lead Sponsor
- Jalo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
All adult patients admitted to the ICU with a diagnosis of organophosphate poisoning will be included.
Age =18 years
Consistent History
Cholinergic toxidrome
Patient recruitment within 12 hours of ICU admission
Written informed consent
Exclusion Criteria
Patients with polypharmacy overdoses were excluded
Patients with a contra-indication to anticoagulation with heparin and enoxaparin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ICU length of Stay
- Secondary Outcome Measures
Name Time Method Mortality ;Serum Organophosphate and Carbamate levels;Cost of ICU stay;Duration and Dose of antidote;Duration of Organ support;Motor Score;Complications